Summary
A mentally retarded boy exhibiting both hyper-11-glyceric acidemia and hyperglycinemia and in whom a deficiency of 11-glycerate dehydrogenase had previously been demonstrated was investigated to elucidate the ethiology of the glycine accumulation and its relationship to the 11-glyceric acid accumulation. It was found that a positive correlation existed between excretion of D-glyceric acid and glycine (coefficient of correlation: r = 0.62. P < 0.001).
that part of the IV injected IL"Clglycine was metabolized to Dglyceric acid whereas no I '"Clglyceric acid was metabolized to glycine. and that the in ~'i:-o degradation of IV injected I '"<')glycine to I4CO2 was diminished. Measurement of glycine cleavage activity in autoptic liver tissue from the patient showed only 10% of nornlal activity. It is argued that this diminished activity could be caused by an endogenous inhibitor. u-glyreric acid is demonstrated not to possess such an inhibitory effect. Based on the finding of increased urinary excretion of both free and conjugated isobutyric acid. 2-methylbutyric acid. and isovaleric acid, it is hypothesized that the diminished glycine cleavage activity might be due, at least partially, to inhibition by 2-methylbutyryl-CoA and isobutyryl-CoA, trio compounds that are known to inhibit the glycine cleavage system.
Speculation
The deranged branched-chain amino acid metabolism demonstrated in this patient is. like the hyperglycinemia, considered to be a secondary phenomenon, possibly caused by the D-glyceric acidemia.
In two previous communications (3. 13) we have described a child with a hitherto unknown inborn error of metabolism named 11-glyceric acidemia.
Judged on the clinical picture and analysis of amino acids in serum, urine. and spinal fluid, this case was indistinguishable from the syndrome of nonketotic hyperglycinemia (17) . a syndrome that has been shown to be due to a defect in the glycine cleavage system. However. when investigating the organic acids in serum and urlne, a large accumula~~un uf ~,-glyce~-~c a c~d was dc~nun-strated. Further studies revealed that leukocytes from the patient had dimin~shed 11-glycerate dehydrogenase activity. I t was therefore proposed that the child suffered from an inborn deliciency of' 11-glycerate dehydrogenase and that the hyperglycinemia was a secondary phenomenon. The suggestion that the hyperglycinemia should be secondary would be analogous to the current concept on the ethiology of the syndrome ketotic hyperglycinemia. This syndrome includes the well-defined inborn errors of metabolism propionyl-C'oA carbuxylase deficiency ( 18). niethylmalonyl-CoA niutase deliciency ( 15). and /I-ketothiolase deficiency ( 10) in which severe hyperglycinem~a has been limnd in addition to the primarily accumulated organic acids. Enzymatic stud~es have demonstrated that the hyperglycinemia seen in ketotic hyperglycinemia is due to diminished glycine cleavage activity (5. 16). although this decreased activity is considered to h e a secondary phenomenon.
The present communication describes the investigations that we have performed to explain the hyperglycinemia seen In our patient. I t is demonstrated that the hyperglycinemia is caused by diminished glycine cleavage activity. a decrease which might. at least partially. be due to inhibition by intramitochondrially accumulated isobutyryl-CoA and 2-methylbutyryl-CoA.
C'ASE KEPOKT The patient. a boy. was a second child of nonconsanguineous emigrants from ~e r h i a .
Pregnancy and birth were uncomplicated. Birthweight was 3.350 g: length was 52 cm. He was hypotonic from birth to a degree that myasthenic paralysis had to be ruled out on the basis of lack of response of neostigmine injection.
At X wk of age. tonic fits with ocular crises developed. In periods. he was in a condition of agitation with persistent motor activity, sometimes described as athetoid movements with difficulties in swallowing. Later. intermittent choreiform movements were seen.
In the course of time. other abnormal paroxysms were noticed such as ( I ) myoclonic jerking with supraversion of eye balls: (2) cerebellar tits throwing him into opisthotonus for a few sec. (3) an almost classical "chor;a minor" quite unusual for his age: (4) universal grand nial sei~ures.
The hyperkinetic movements were partly controlled on phenobarbital or nitra~epam and later phenytoin combined with klonazepam. He never fixated and followed the light and never spontaneously tried to raise his head from the supine position. He was not able to grasp and could not coordinate any of his movements. He remained completely mentally extinguished and hypotonic and died at the age of 3': years from pneumonia.
The patient was fed normal diet and never had acidotic episodes. and growth and body weight remained normal for age.
The following compounds were synthesi~ed as previously described: 1)-glyceric acid (3). 3-hydroxy-isobutyric acid. 2-methyl-3-hydroxy-butyric acid, and 3-hydroxy-isovaleric acid (12). 2-Hydroxy-caproic acid was synthesized by reduction of 2-oxocaproic acid with sodiuni borohydride followed by purification of the product by sil~cic acid chromatography according to Kessner and Muntwyler ( I I ) . Tetrahydrokdic a c~d was synthesi~ed as previously described ( 6 ) . [I-"CjGlycine was obtained from New England Nuclear C'orp.. West Germany. 1,) -[I-"('1Clyceric acid was obtained from CEA. France. All other reagents used were of i~nalytical grade. added. and "C activity was counted. The identity and purity of Cilycine concentrations in urine were measured on a Technicon amino acid analyzer. Cilyceric acid concentrations in urine were measured gas chromatographically (Hewlett-Packard 5830 A) as trimethylsilyl derivatives after isolation of the organic acids by ion-exchange chromatography on Sephadex A-25 according to Chalmers and Watts (4) . Pimilic acid was used as internal standard. Urinary branched-chain amino acid metabolites were identified and quantified by a multiple ion detection system (MID). The instrument used was an AEI MS 30 mass spectrometer equipped with a 5-channel multiple ion detector and a ~~e -~n i c a n l kas chromatograph. Volatile monocarboxylic acids were analyzed before and after alkaline hydrolysis at 110°C for 24 hr. The acids were isolated by vacuum distillation according to Ando et al. (2) and separated on a Porapac (23) trimethylchlorosilane at 60°C for 10 min. Separation was performed on an OV-l column by programming the oven from 100°C with 10°C per min. MID-ions: 3-hydroxypropionic acid and 3-hydroxyisobutyric acid. 177.0834: 2-methyl-3-hydroxy butyric acid. 2 19.0940: internal standard (2-hydroxycaproic acid), 261.1384. Measurement of 3-hydroxyisovaleric acid proved unsatisfactory in the MI[)-syxtern ;rnd was rnc;r.\ured gas chruni~tograpl~ically on a Hewlett-Packard 5830 A gas chromatograph with the same column and by programming the oven from 60" with 4OC'/min. I 4 C-Labeled amino acids and organic acids in the urine were isolated and quantified in the following way. A urine sample was put onto a 2-x 12-cm column of Sephadex A-25. The column was washed with 20 ml water. and the total eluate was collected (fraction A). The column was then eluted with 30 ml 2.5 M pyridinium acetate (fraction B). I'reliminary experiments with fraction A showed that the amino acids were not retained on the column and were eluted in the lirst 10 to IS ml of this liaction.
leaving the last 5 to 10 ml free of amino ac~ds. Similarly, it has been ascertained both by us and by others (4) that when using 30 ml 2.5 M pyridiniurn acetate a very high recovery of organic acids is obtained in fraction B. This recovery was tested for glyceric acid and was found to be above 95";.
Fraction A was lyophili/.ed. and redissolved in water. and the amino acids were separated on a Rank Hilger. Chromaspek amino acid analyrer. using fluorescence detect~on. The eluate was collected in fractions after detection. and transferred to counting vials containing lnstagel (22) I1'C]activity was counted in a Packard liquid scint~llation counter.
Fraction B was also lyophilired (in alkaline solution). dissolved in 0.05 N sulphuric acid ( 0°C ' ) . and subjected to silicic acid chromatography according to Kessner and Muntwyler ( I I ) . The eluate was collected in 10-ml fractions wh~ch were transferred to counting vials. The organic phase was evaporated (after addition of 100 pI 0.5 N sodium hydroxyde to each tiaction). lnstagel was I .I C-labeled compound.; were further determined b; radiokas chromatography of trimethylsilyl derivatives of the evaporated remnants of radioactive fractions. The radiogas chromatograph was a modified Hewlett-Packard 7620 A model where a splitter had been introduced between column and flame ionization detector. Thus. 15':i' of the helium flow reached the flame ionization detector. and 85'7 passed through a steel funnel to the outside of the oven. Here the organic acids separated on the column were trapped by placing Pasteur pipets containing glass wclol soaked with Protorol (23) beneath the exit of the funnel. The Pasteur pipets were changed manually each 30 sec. The soaked glass wool was then transferred to counting vials. and after addition of scintillation fluid. "C activity was measured.
To monitor the in vivo formation of " c O~ after IV injection ol [I-"~]glycine, expiration air was collected in meteorologic balloons during 5-min periods spread over a 2-hr interval immediately following injection. Total C 0 2 was measured by titration with sodium hydroxyde after trapping in a mlxture of ethanolamine:methylcellosolve (2: I ) according to Fredrickson and Ono (7). " '~0~ was measured by counting samples ofthe same solutions in a liquid scintillation counter. In vivo fbrmation of "CO? was expressed relatively as dpm/mmole C O expired.
Glycine cleavage activity in human liver tissue was measured by collecting " C 0 2 liberated from [ I-"Clglycine during incubation with liver homogenate as previously described (8. 12) [reaction mixture: 4.75 p o l e s glycine (specific activity. 0.6 mCi/mmole) 0.5 pmole tetrahydrofolic acid, 0.8 pmole pyridoxal phosphate. 2.5 pmoles dithiotreitol. 0.8 pmole adenine-dinucleotide. 67.5 pmoles Tris-HCI (pH 8.1 ). 4 mg protein. total volume 1.0 ml].
Cilycine cleavage activity was expressed in nmclles glycine metabolized per mg protein per hr. Protein was measured according to Lowry er ul. ( 14) .
Inhibitory studies on the glycine cleavage system were perlilrmed on freshly prepared ratliver mitochondria and on acetonedried rat liver mitochondria1 powder as previously described ( 12). Reaction mixture for assays using fresh mitochondria was identical to the reaction mixture described above. Reaction mixture when using the solubilized system was: 4.75 pmoles glycine (specific activity. first occasion, 50 pCi [I-"'Clglycine was given. and I I days later. 50 pCi ~~. -[ l -'~C ] g l y c e r i c acid was given. In both cases. urine was collected the following 24 hr and examined for "C activity in amino acids and organic acids. When Il-"CJglycine was administered. activity was found in both the organic acid fraction and in the amino acid fraction. In the amino acid fraction. the radioactivity was almost exclusively localized in glycine. In addition, trace amounts of '"C activity was found in serine and cystathionine. The organic acid fraction showed only one "C-labeled peak on silicic acid chromatography with a retention time similar to glyceric acid. The identity and purity of this compound was further verilied by radiogas chromatography. which also showed one peak with retention time similar to that of glyceric acid.
When administering ~)i.-[l-"C]gl~ceric acid. no activity was found in the amino acid fraction. In the organic acid fraction. one I I C-labeled peak was found. This was identified as glyceric acid. The results are summarized in Table I . at intervals over the fc>llowing 120 min. The results are shown graphically in Figure 2 . In this experiment, no control was included. Instead. the results found by earlier investigators ( 17) concerning the shape of this curve in normal persons and in patients with nonketotic hyperglycinemia are shown as .c./ruJc~f arru.s. It is quite evident that in this respect the patient closely resembles what has been found in patients with nonketotic hyperglycinemia. Gl,,i,inc Cleu,'u~c /lc,rit'iri. in Livcr Tis.slrr. Autoptic liver tisaue was obtained 6 hr post morlenl from [he patrenl and kept at -20°C' until measurement of the glycine cleavage system was performed. As controls. two samples of autoptic liver tisaue were used (obtained 7 and 10 hr post mortem) from two children who had died of congenital heart disease. and a surgical liver biopsy from a child with mild hepatic stasis was used. The results of the glycine cleavage measurements are shown in Table 2 .
To eliminate errors due to membrane transport. the inhib~tory studies were performed on freshly prepared rat liver mitochondria and, additionally. on the solubilized glyctne cleavage system. These investigations showed that I>-glyceric acid in the concentration range 0.3 to 10.0 mnioles/liter had no significant eH'ect on the glycine cleavage system in either fresh mitochondria or in the solubilized system. 
EXC'KtTION OF BRAN('tiEL)-('H.41N AMINO /\('ID METABOLITES
Five 24-hr urine samples were collected from the patient over a period of 2 years. The patient was on all these occasions in his habitual condition. 1.e.. without signs of illness apart from the severe cerebral damage. As controls. 24-hr urine samples from five normal children aged 2 to h years were used. Determination of branched-chain amino acid metabolites showed undetectable amounts of 2-oxo-acids (limit of detection. I pg/mg creatinine) and unsaturated short-chain fatty acids (limit of detection, I pg/ mg creatinine for unhydrolyzed compounds) in both patient and controls. However, for the hydroxyacids and for both free and total short-chain fatty acids. significant elevation was demonstrated in all urine samples from the patient compared to the control children (Table 3) .
DISCUSSION
The striking feature in this patient with a typical nonketotic hyperglycinemia syndrome is the accumulation of I,-glyceric acid in addition to the glycine accumulation. Inasmuch as 1)-glyceric acid has never been found accumulated in any other cases of hyperglycinemia (17. 18) . we believe that this new syndrome represents a separate entity.
I n an earlier-communication ( 13), we presented evidence for a diminished D-glycerate dehydrogenase activity in the patient. and we therefore proposed that the 11-glyceric acid accumulation might be caused by an inborn deficiency of this ent.yme (Fig. 3) . The primary aim of the present communication is to investigate the ethiology of the glycine accumulation. and efforts were concentrated on demonstrating if a diminished enzyme activity could be demonstrated in the glycine degradation. Because our patient clinically resembled the syndrome nonketotic hyperglycinemia. The main objection to this is that the large body pool of glycine will itself cause a slow rise and a low peak value due to dilution of the labeled glycine. Attempts to overcome this objection were made by Ando et al. ( I ) by infusing large amounts of glycine to control children to increase the body pool. They succeeded in raising the serum glycine concentration to the same level as seen in patients and keeping it here for about 60 min before the experiment was performed. Results from controls under these conditions still revealed peak excretion after 15 min and a rise to 20 to 30 nCi/mmole x 10 '. Whether this is conclusive is difficult to say because it is impossible to judge if this artificial glycine accumulation had spread to all compartments including the mitochondrial cornparimen[ containing enzymes for glycine degradation. It is therefore still debatable to what extent this tyDe of in , .
viva experiment gives specific information about the degradation of glycine in hyperglycinemia patients. However, an experiment of this type was performed on our patient. and 
S7'UDIES OF GLYC'INE METABOLISM
10.33 that the respiratory excretion pattern of I4CO2 closely resembles what has been found in patients with nonketotic hyperglycinemia. Attention was then focused on the glycine cleavage system, which has been shown to be diminished in varying degree in both ketotic and nonketotic hyperglycinemia. In our patient, we found activity about 10% of normal. which seems to cclrrespond well with the fact that the clinical picture resembles classic nonketotic hyperglycinemia (19).
We are thus faced with a patient with what seems to be two distinct enzyme deficiencies and consequently two different accumulations. Because the probability of one child with two totally independent inborn errors of metabolism is extremely small, we are of the opinion that only one accumulation is due to a primary enzyme defect and that the other is a secondary phenomenon. The following points can be made in favor of the glycine accumulation being primary: ( I ) the clinical picture closely resembles the syndrome nonketotic hyperglycinemia where the current concept is that this disorder is due to an inborn error in the glycine cleavage system. The disproportionately high spinal fluid glycine concentration is considered especially typical for nonketotic hyperglycinemia ( 19): (2) the glycine cleavage system is diminished to a level which agrees with what has been found in patients with nonketotic hyperglycinemia.
The following points can be made against the hypothesis that the glycine accumulation is primary: ( I ) in no other patients with hyperglycinemia has there been demonstrated accumulation of D-glyceric acid. making it highly unlikely that his accumulation should be caused by the hyperglycinemia; (2) (Table I ) suggesting only a partial deficiency of the glycine cleavage system and trapping of the degraded I4C atoms in I,-glyceric acid; (3) 1,-glycerate dehydrogenase was deficient in the patients' cells, and this deficiency was, in view of results from the mixing experiments. not due to inhibition (13); (4) secondary hyperglycinemia has repeatedly been described in connection with other organic acidurias. namely propionyl-CoA carboxylase deficiency, methylmalonyl-CoA mutase deficiency, and P-ketothiolase deficiency.
The following points can be made in favor of the D-glyceric acid accumulation being primary: ( I ) deficient D-glycerate dehydrogenase not due to inhibition; (2) partial support is given by the observation that only undetectable amounts of D-glyceric acid were converted to glycine in vivo, suggesting a much-more extensive defect in the degradation of D-glyceric acid than in the degradation of glycine (Table I) . Because no observations have been obtained contradicting the hypothesis that the D-glyceric acid accumulation is primary, we are at present of the opinion that the child suffered from an inborn deficiency of D-glycerate dehydrogenase and that the hyperglycinemia was a secondary phenomenon.
The data in Figure I show that a positive correlation exists between the glycine accumulation and the mglyceric acid accumulation. Because it can be ruled out that a part of the accumulated I>-glyceric acid is converted to glycine (Table I) . this correlation seems to suggest that the glycine cleavage system is somehow influenced by the 11-glycerate dehydrogenase deficiency. A llkely mechan~bn~ I'or (hi5 could be that a cor~~pound accunlulaled because of the n-glycerate dehydrogenase deficiency inhibits either the activity or the synthesis of the glycine cleavage system. In this case. inhibition of activity seems most likely because the concomitant alterations in excretion of the two compounds can take place relatively fast. We have thus observed an almost 100% increase in excretion of both compounds within 2 wk (glycine, 53.7 pmoles/mg creatinine to 107.8 pmoles/mg creatinine; 1,-glyceric acid: 263.2 pmoles/mg creatinine to 459.4 pmoles/mg creatinine). The most likely candidate for such an inhibitor would of course be I>-glyceric a c~d . I t was therefore investigated whether n-glyceric acid might inhibit the glycine cleavage system, a mechanism that would correspond well with the current concept on the ethiology of ketotic hyperglycinemia (18) . No inhibition could.
however. be demonstrated. a result that is in accordance with the recent finding of a child with D-glyceric acidemia but without hyperglycinemia (20) .
Bearing in mind the analogy to the ketotic hyperglycinemia syndrome, the possibility of other endogenous inhibitors of the glycine cleavage system was then considered. Efforts here were concentrated on metabolites of the branched-chain amino acids.
firstly because the existence of the syndrome ketotic hyperglycinemia seems to indicate that deranged branched-chain amino acid metabolism can affect the glycine cleavage activity and secondly because in a previous communication, we have demonstrated that 2-methyl-butyryl-CoA and isobutyryl-CoA possess strong inhibitory action on the glycine cleavage system (12). The results in Table 3 indicate that the metabolism of the branched-chain amino acids is in fact severely deranged in the patient, with elevated excretion of a variety of metabolites. The elevated excretion of isobutyric acid, 2-methyl-butyric acid, and isovaleric acid after alkaline hydrolysis is striking. We consider these acids derived from conjugates, especially glycine conjugates because it is well documented, that accumulations of short-chain fatty acids in patients with a number of organic acidurias results in excretion of the corresponding glycine conjugates. In this context. it is interesting that these accumulations of branched-chain amino acid metabolites are constantly present and not. as described for glutaryl-CoA dehydrogenase deficiency, associated with severe intercurrent infections (9) .
Although the ethiology of this deranged branched-chain amino acid metabolism is at present unknown, the constant occurrence of free and especially of conjugated isobutyric acid, 2-methylbutyric acid, and isovaleric acid in urine seems to indicate that there exists an analogous intramitochondrial accumulation of the corresponding thiolesters. two of which, as mentioned, cause strong inhibition of the glycine cleavage system. It is therefore suggested that these accumulations play an ethiologic role in the diminished glycine cleavage activity found in liver tissue from the patient.
Finally. the possibility of inborn defect in a common factor for both enzymes must be considered. Both mglycerate dehydrogenase and the glycine cleavage system are in principle NAD-requiring dehydrogenases. but nothing is known about any common structural element in the two enzymes. One thing might perhaps be counted in favor of this possibility, namely the fact that Wadman el al. (20) have described a child with D-glyceric acidemia, but with a clinical picture totally different from our patient and with no hyperglycinemia. In this child, no enzyme measurements were performed due to loss of contact with the patient. Assuming that this child also had an inborn deficiency of Dglycerate dehydrogenase. this might at least imply that more than one structural defect in this enzyme can exist. It can. however. also be speculated that the difference in hyperglycinemia between our patient and the one described by Wadman el al. could reflect the interindividual variation in tendency to hyperglycinemia known in patients with propionyl-CoA carboxylase deficiency. methylmalonyl-CoA mutase deficiency. and P-ketothiolase deficiency, thus suggesting that the two children suffered from the same inborn enzyme defect.
